Hip Arthropathy
94
18
25
46
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
2.1%
2 terminated out of 94 trials
95.8%
+9.3% vs benchmark
17%
16 trials in Phase 3/4
15%
7 of 46 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 46 completed trials
Clinical Trials (94)
VR Effects After Hip Replacement Surgery Pain
CoCrMo LOCK Bipolar Femoral Heads FU
Ambispective Study to Assess the Safety and the Performance of SAGITTA EVL R Stem
Comparison of Direct Anterior and Posterior Surgical Approaches in Regards to the Patient' Physical Characteristics
Restoration Anatomic Acetabular Shell Revision Study
PENG vs L-ESPB With S-ESPB for Analgesia in Total Hip Arthroplasty
Cryoneurolysis in Patients Awaiting Total Hip and Knee Arthroplasty
Assessment of Safety and Performances of HYPE Stems Associated to a SERF Acetabular Cup in Hip Arthroplasty (2017-01-NH)
Prospective and Obsevational Study of Total Hip Prothesis: HYPE Stem
Assessment of Safety and Performances of HYPE SCS Stem Associated to NOVAE Sunfit TH Acetabular Cup in Hip Arthroplasty
Hip Prospective Study
Marrow Cellution™ vs. Traditional BMA Harvest Project
Pericapsular Nerve Group (PENG) Block Combined With Lateral Femoral Cutaneous Nerve (LFCN) Block or Wound Infiltration for Postoperative Analgesia in Anterior Approach Total Hip Arthroplasty: A Randomized Controlled Trial
Knee-hip Surgery Wait-list Support Program
Cardiac Index and General Anesthesia Without Opioid.
PENG Block Optimization: Volume and Dexamethasone Effects
Radiographic Stability of Hip Prosthesis Prior to Revision Surgery
Optimized MRI of Patients With Hip Arthroplasty
Nexus Evaluation Primary Trident II Uncemented Shell
NLR and PLR Levels Following PENG Block in Hip Arthroplasty